CurrentCardio
Get Weekly

Topic · page 8 of 18

Valvular & structural heart disease

Aortic, mitral and tricuspid disease, TAVI/TEER, surgical valve therapy, PFO/LAA closure

Briefs 281–320 of 696 placed here, newest publication first

Briefs in Valvular & structural heart disease

Newest publication first

  1. ESC Heart Fail

    Impact of maintaining mild mitral regurgitation beyond 1 year after mitral transcatheter edge-to-edge repair

    Cohort study

  2. JACC Cardiovasc Interv

    Long-Term Outcomes After Melody Transcatheter Pulmonary Valve Implant in Patients Weighing ≤30 kg

    Cohort study

  3. Circulation

    Multivalve Involvement in Aortic Stenosis: Insights From a Narrative Review

    Research article

  4. JACC Cardiovasc Interv

    Early U.S. Real-World Experience With a Novel Intra-Annular Self-Expanding Valve for Transcatheter Aortic Valve Replacement

    Cohort study

  5. JACC Cardiovasc Interv

    Atrial Fibrillation and Tricuspid Regurgitation in Patients Undergoing Mitral Valve Transcatheter Edge-to-Edge Repair

    Cohort study

  6. Circ Cardiovasc Interv

    Outcomes of Patients With New Left Bundle Branch Block After TAVR: TVT Registry Insights

    Cohort study

  7. JAMA Cardiol

    Tenecteplase vs Alteplase in Mechanical Prosthetic Heart Valve Thrombosis: The TENET Randomized Clinical Trial

    Randomised controlled trial

  8. Heart

    Multisystem comorbidities and shared genetic pathways in calcific aortic stenosis: a phenome-wide and Mendelian randomisation analysis

    Diagnostic or prognostic study

  9. JACC Cardiovasc Interv

    Mid-Term Outcomes of a Novel TAVR Device for Pure Aortic Regurgitation: A Prospective, Multicenter Trial

    Cohort study

  10. Eur Heart J

    Physiology vs angiography-guided percutaneous coronary intervention in transcatheter aortic valve implantation: the FAITAVI trial

    Randomised controlled trial

  11. JACC Cardiovasc Interv

    Comparison of Early Outcomes Following Transjugular Transcatheter Tricuspid Valve Replacement Between Large vs Small Annulus

    Cohort study

  12. JACC Cardiovasc Interv

    The Prognostic Value of Right Ventricle–Pulmonary Artery Coupling in Valve Interventions: Systematic Review and Meta-Analysis

    Meta-analysis

  13. JACC Cardiovasc Interv

    Cardiac Remodeling Following Transcatheter Tricuspid Valve Annuloplasty for Tricuspid Regurgitation: A Real-World, Multicenter Analysis

    Cohort study

  14. JACC Cardiovasc Interv

    Cardiac Remodeling After Transcatheter Tricuspid Valve Replacement: Insights From Multimodality Imaging

    Cohort study

  15. JACC Cardiovasc Interv

    1-Year Outcomes of TAVR With ACURATE neo2 vs SAPIEN/Evolut: A SWEDEHEART Target Trial Emulation Study

    Cohort study

  16. JACC Cardiovasc Interv

    Clinical Impact of In-Hospital Hemoglobin Decline Without Overt Bleeding After Transcatheter Aortic Valve Replacement

    Cohort study

  17. JACC Cardiovasc Interv

    Effect of Transcatheter Aortic Valve Replacement Program Ratings on Case Selection

    Cohort study

  18. JACC Cardiovasc Interv

    Outcomes of Early vs Delayed Aortic Valve Replacement: Analysis of the EARLY TAVR Valve Implant Population

    Secondary analysis

  19. Lancet

    Transcatheter aortic valve implantation with the Trilogy valve for symptomatic native aortic regurgitation (ALIGN-AR): a pivotal, multicentre, single-arm, investigational device exemption study

    Cohort study

  20. J Am Coll Cardiol

    1-Year Outcomes of Novel Balloon-Expandable vs Contemporary Transcatheter Heart Valves in Severe Aortic Stenosis: The LANDMARK Trial

    Randomised controlled trial

  21. JACC Cardiovasc Interv

    Double Inflation (“Double Tap”) on Valve Expansion and Short-Term Outcomes After the Latest-Generation Balloon-Expandable TAVR

    Cohort study

  22. J Am Coll Cardiol

    Proactive Management and Treatment of Aortic Stenosis: An International Expert Perspective

    Guideline or statement

  23. JACC Cardiovasc Interv

    Long-Term Impact of Mild Paravalvular Regurgitation After Transcatheter Aortic Valve Replacement: The OCEAN-TAVI Registry

    Cohort study

  24. JACC Cardiovasc Interv

    Real-Time Fluoroscopic Assessment of Underexpansion Predicts Hemodynamic Valve Deterioration Following TAVR With Balloon-Expandable Device

    Cohort study

  25. Circulation

    Quantitative Identification of High-Risk Tricuspid Regurgitation by Cardiac Magnetic Resonance

    Cohort study

  26. J Am Coll Cardiol

    Using Transmitral Pressure Gradients and Residual Mitral Regurgitation to Optimize Outcome After Transcatheter Edge-to-Edge Repair

    Cohort study

  27. JACC Cardiovasc Interv

    6-Month Outcomes of a Supra-Annular Transcatheter Mitral Valve Replacement: An Early Feasibility Study

    Research article

  28. JAMA Cardiol

    Contemporary Incidence and Procedural Volume of Transcatheter Aortic Valve Reintervention

    Cohort study

  29. JAMA Cardiol

    Transcatheter or Surgical Treatment of Patients With Aortic Stenosis at Low to Intermediate Risk: An Individual Participant Data Meta-Analysis

    Meta-analysis

  30. JACC Cardiovasc Imaging

    Cardiac Remodeling and Outcomes of Patients With Combined Aortic and Mitral Regurgitation

    Cohort study

  31. JACC Cardiovasc Imaging

    Tricuspid Anatomic Regurgitant Orifice Area by Cardiac Computed Tomography: Novel Outcome Insights

    Diagnostic or prognostic study

  32. J Am Coll Cardiol

    Transcatheter Mitral Valve Replacement for Severe Mitral Annular Calcification: Primary Outcomes From the SUMMIT-MAC Study

    Cohort study

  33. N Engl J Med

    Transcatheter or Surgical Aortic-Valve Replacement in Low-Risk Patients at 7 Years

    Randomised controlled trial

  34. JACC Cardiovasc Interv

    Clinical Outcomes of Redo Transcatheter Aortic Valve Replacement According to Computed Tomography Sizing

    Cohort study

  35. JACC Cardiovasc Interv

    Impact of Early Hemodynamic Valve Deterioration on Long-Term Outcomes Following Transcatheter Aortic Valve Replacement

    Cohort study

  36. JACC Cardiovasc Interv

    Long-Term Outcomes in Moderate and Severe Aortic Stenosis According to Extent of Cardiac Damage

    Meta-analysis

  37. JACC Cardiovasc Interv

    Impact of Valve Frame Height on PCI Outcomes After TAVR

    Cohort study

  38. JACC Cardiovasc Interv

    Transcatheter Tricuspid Valve Replacement and CLEFT After Tricuspid TEER

    Cohort study

  39. JACC Cardiovasc Interv

    Tricuspid Valve Transcatheter Edge-to-Edge Repair in Patients With Cardiac Implantable Electronic Devices: Insights From EuroTR

    Cohort study

  40. JACC Cardiovasc Interv

    Hypoattenuated Leaflet Thickening and Reduced Leaflet Motion After Transcatheter Tricuspid Valve Replacement

    Cohort study

All 696 Briefs in ExploreShowing Briefs 281–320 of 696, newest first